References

  1. Bauersachs R, Debus S, Nehler M, et al: A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery Disease. Angiology 2020; 71: 303-314
  2. GBD 2017 DALYs and HALE Collaborators: Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1260-1344
  3. Monreal M, Agnelli G, Chuang LH, et al: Deep Vein Thrombosis in Europe-Health-Related Quality of Life and Mortality. Clin Appl Thromb Hemost 2019; 25: 1076029619883946
  4. Willich SN, Chuang LH, van Hout B, et al: Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work. Thromb Res 2018; 170: 181-191
  5. Chuang LH, Cohen AT, Agnelli G, et al: Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis. Qual Life Res 2019; 28: 1155-1177
  6. Bauersachs R, Schellong SM, Haas S, et al: CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency. Thromb Haemost 2011; 105: 981-988
  7. Schellong SM, Gerlach HE, Tebbe U, et al: Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY study. Thromb Res 2011; 128: 417-421
  8. Bauersachs RM, Lensing AW, Prins MH, et al: Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment. Thromb J 2015; 12: 25
  9. Bauersachs RM, Herold J: Oral Anticoagulation in the Elderly and Frail. Hamostaseologie 2020; 40: 74–83
  10. Bauersachs RM, Dudenhausen J, Faridi A, et al: Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007; 98: 1237-1245
  11. Décousus H, Leizorovicz A, Bauersachs R, et al: Fondaparinux for the treatment of superfical-vein thrombosis in the legs N Engl J Med 2010; 363: 1222-1232
  12. Beyer-Westendorf J, Schellong SM, Gerlach H, et al: Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol 2017; 4: e105-e113
  13. Bauersachs R, Gerlach HE, Heinken A, et al: Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT). Eur J Vasc Endovasc Surg. 2021 Aug;62(2):241-9.2021/07/03.
  14. Reinecke H, Jurgensmeyer S, Engelbertz C, et al: Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study. BMJ Open 2018; 8: e022690
  15. Lee AY, Bauersachs R, Janas MS, et al: CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer 2013; 13: 284
  16. Bauersachs R, Lee AYY, Kamphuisen PW, et al: Long-Term Tinzaparin Versus Warfarin For Treatment Of Venous Thromboembolism In Cancer Patients – Analysis Of Renal Impairment In The Catch Study. Journal of Thrombosis and Haemostasis 2015; 13:
  17. Agnelli G, Becattini C, Meyer G, et al: Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. N Engl J Med 2020; 382: 1599-1607
  18. Martinez-Zapata MJ, Mathioudakis AG, Mousa SA, Bauersachs R: Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost 2018; 24: 226-234
  19. Bauersachs R, Berkowitz SD, Brenner B, et al: Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499-2510
  20. Weitz JI, Lensing AW, Prins MH, et al: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med 2017; 376: 1211-1222
  21. Weitz JI, Bauersachs R, Becker B, et al: Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA 2020; 323: 130-139
  22. Aboyans V, Bauersachs R, Mazzolai L, et al. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. Eur Heart J. 2021 Jul 19.2021/07/20.
  23. Stute P, Kiesel L, Bauersachs R, Beyer-Westendorf J, Bühling K: Hormonal Contraception. Guideline of the German Society of Gynecology and Obstetrics (S3-Level, AWMF Registry No. 015/015, December 2018). Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften eV (AWMF) 2019:
  24. Kakkos SK, Gohel M, Baekgaard N, Bauersachs R et al Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg. 2021 Jan;61(1):9-82.2020/12/19.
  25. Bauersachs R, Lindhoff-Last E, Ehrly AM, Kuhl H: [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives]. Zentralbl Gynakol 1996; 118: 262-270
  26. Bauersachs RM, Lindhoff-Last E, Ehrly AM: [Ambulatory treatment of an acute pulmonary artery embolism in fresh thigh vein thrombosis using low-molecular-weight heparin]. Dtsch Med Wochenschr 1999; 124: 1485-1488
  27. Bauersachs R, Lindhoff-Last E, Wolff U, Ehrly A: Aktuelles Management der tiefen Venenthrombose. Med Welt 1998 1998; 49: 194-214
  28. Schellong SM, Riess H, Spannagl M, et al: [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status]. Internist (Berl) 2018; 59: 744-752
  29. Omran H, Bauersachs R, Rubenacker S, Goss F, Hammerstingl C: The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 2012; 108: 65-73.
  30. Bauersachs RM, Schellong S, Haas S, et al: Überbrückung der oralen Antikoagulation bei interventionellen Eingriffen. Dtsch Arztebl 2007; 104: 1237-1244
  31. Bauersachs R, von Heymann C, Kemkes-Matthes B, et al: Blutungsrisiko und Nierenfunktion bestimmen das Vorgehen: Empfehlungen zum perioperativen Umgang mit direkten oralen Antikoagulanzien (DOAKs) und thrombozytenaggregations­hemmenden Substanzen. Dtsch Arztebl 2019; 116. : A 1894-1898
  32. Krabbe B, Bauersachs RM: [Bridging in patients with long-term oral anticoagulation - new recommendations]. Dtsch Med Wochenschr 2016; 141: 157-160
  33. Bauersachs R: [Prolonged Secondary Prevention After Venous Thromboembolism]. Dtsch Med Wochenschr 2018; 143: 137-142
  34. Mazzolai L, Ageno W, Alatri A, Bauersachs R, et al. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function. Eur J Prev Cardiol. 2021 Jul 13.2021/07/14.
  35. Gohlke-Barwolf C, Pildner von Steinburg S, Kaemmerer H, Regitz-Zagrosek V: [Anticoagulation and thrombophilia in pregnancy.]. Internist (Berl) 2008:
  36. Schleussner E, Kamin G, Seliger G, et al: Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Ann Intern Med 2015; 162: 601-609
  37. Linnemann B, Bauersachs R, Rott H, et al: Diagnosis of pregnancy-associated venous thromboembolism - position paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH). Vasa 2016; 45: 87-101
  38. Linnemann B, Scholz U, Rott H, et al: Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH). Vasa 2016; 45: 103-118
  39. Kher A, Bauersachs R, Nielsen JD: The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Thromb Haemost 2007; 97: 505-513
  40. Hart C, Bauersachs R, Scholz U, at al. Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH). Hamostaseologie. 2020 Dec;40(5):572-90.2020/06/27.
  41. Herold J, Bauersachs R: The lower leg vein thrombosis – a disease for specialists. Phlebologie 2018; 47: 319-328
  42. Bauersachs R, Langer F, Kalka C, et al: Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies. Vasa 2019; 48: 483-486
  43. Linnemann B, Bauersachs R, Grebe M, et al: Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Vasa 2020; 49: 259-263